Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Microbiological Methods|March 13, 2026
Development and validation of a propidium monoazide-qPCR assay with matrix-matched calibration for selective quantification of viable Limosilactobacillus reuteri in multi-strain probiotic powdersJinho Lee, Jin Seok Moon
Food Science and Biotechnology|December 7, 2019
Correction to "Application of in vitro gut fermentation models on food components: a review" [Food Sci. Biotechnol. 25: 1-7(2016)]Jin Seok Moon, Ling Li, Jeongsu Bang, et al.
Food Science and Biotechnology|September 29, 2018
Application of in vitro gut fermentation models to food components: A reviewJin Seok Moon, Ling Li, Jeongsu Bang, et al.
Journal of Microbiology and Biotechnology|November 27, 2025
Gut Microbiota Modulation by Lacticaseibacillus paracasei EFEL6501 Ameliorates Muscle AtrophyGeum Na Pyeon, Hyunbin Seong, Jin Seok Moon, et al.
Food Science & Nutrition|April 20, 2026
Comparison of Viable and Heat-Inactivated Lacticaseibacillus rhamnosusIDCC 3201: Anti-Pathogenic, Anti-Inflammatory, and Microbiota Modulating EffectHayoung Kim, Hanbin Lee, Won Yeong Bang, et al.
Biotechnology Letters|July 21, 2009
Heterologous expression and secretion of Lactobacillus amylovorus alpha-amylase in Leuconostoc citreumHyun-Ju Eom, Jin-Seok Moon, Eun-Young Seo, et al.
Food Science & Nutrition|May 1, 2026
Immune-Enhancing Effects of IBP35, a Combination of Lactiplantibacillus plantarum and Ligilactobacillus salivarius, in Macrophages and Cyclophosphamide-Induced Immunosuppressed MiceHan Bin Lee, Jinho Lee, Kyuho Jeong, et al.
Probiotics and Antimicrobial Proteins|April 18, 2024
Effects of Limosilactobacillus reuteri ID-D01 Probiotic Supplementation on Exercise Performance and Gut Microbiota in Sprague-Dawley RatsYe-Ji Jang, Han Sol Choi, Ikhoon Oh, et al.
Current Opinion in Biotechnology|July 17, 2026
Health-directed starter cultures for fermented foods: translating multi-omics into functional designJin Seok Moon, Won Yeong Bang, Jinho Lee, et al.
Journal of Microbiology and Biotechnology|January 25, 2026
Randomized, Double-Blind, Placebo-Controlled Trial of ID-CBT5101, a Tyndallized Clostridium butyricum Postbiotic, in Adults with Mild-to-Moderate Knee OsteoarthritisHan Bin Lee, Jinho Lee, Kyuho Jeong, et al.
Pageof 5